David Anschel, MD
Neurology · Port Jefferson, NYNPI 1689620387
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $19,490 of the $27,202 with a category attached, or 71.6%. Neurelis, Inc. accounts for 72.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $11,640 and has fallen 89.4% since, to $1,229 in 2025.
Across 121 payments — averaging $224.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$20K
- Medtronic$2K
- Livanova USA, Inc.$1K
- SK Life Science, Inc.$1K
- Greenwich Biosciences, Inc.$445
- Biogen$441
- plus $2K from 14 others
What the payments were for
- Speaking & faculty fees$19,49072%
- Travel & lodging$1,9747%
- Food & beverage$5,67521%
- Education$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 23 | $19,640 |
| Medtronic | 21 | $2,296 |
| Livanova USA, Inc. | 8 | $1,380 |
| SK Life Science, Inc. | 28 | $1,290 |
| Greenwich Biosciences, Inc. | 13 | $445 |
| Biogen | 4 | $441 |
| AstraZeneca(2 entities) | 2 | $256 |
| UCB, Inc. | 2 | $197 |
| Viatris Specialty LLC | 3 | $186 |
| Neuropace, Inc. | 2 | $158 |
| Cadwell Industries, Inc | 1 | $156 |
| Sunovion Pharmaceuticals Inc. | 2 | $149 |
| AbbVie | 1 | $125 |
| Aquestive Therapeutics, Inc. | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 2 | $119 |
| Lundbeck LLC | 1 | $97 |
| Zogenix Inc. | 4 | $89 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Abbott | 1 | $18 |
| Biomarin Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$19,211
- STEALTHSTATION S8 PLATFORM$1,679
- VNS - Sentiva$787
- VNS Therapy$521
- Epidiolex$141
- RNS Neurostimulator Kit$134
- CALQUENCE$131
- APTIOM$125
- TYSABRI$125
- Yupelri$125
- SYMPAZAN$125
- QULIPTA$125
- UBRELVY$125
- XCOPRI$122
- TECFIDERA$121
How this compares
$27,202 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Port Jefferson
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
- Richard LiptonBronx$753K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.